AVITA Medical Inc（RCEL）價格預測

$15.510

+0.090 (+0.58%)收盤時

價格預測

1-Day Price Prediction

-0.67%

1-Week Prediction

+1.78%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RCEL 相似圖表分析預測

Alphio's RCEL stock price prediction model matches the current AVITA Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.41 (-0.67%). The 1-week path is $15.79 (+1.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 AVITA Medical Inc 股票嗎？

AVITA Medical Inc. (RCEL) appears to be a good buy right now due to its current price of $15.51, which is well below the analyst price target of $15, suggesting a potential upside. The stock has shown impressive performance with a year-to-date change of +346.97% and a 5-day change of +18.94%, indicating strong momentum. However, the main risk is the negative net income, which was -$7.66 million in Q2 2026, highlighting ongoing financial challenges that investors should consider.

RCEL 股價於 Friday 收在 $15.51，此前上漲 +0.58%

AVITA Medical Inc (RCEL) last closed at $15.51, gaining +0.58%. These facts feed the 1-day and 1-week RCEL price prediction above.

預測驅動因素

AVITA Medical Inc（RCEL）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 RCEL 最接近的股票，依相似度排序。

SCHW

92.54%

+39.00%

CALX

91.88%

+7.59%

KURA

91.52%

+16.86%

HUN

91.22%

-13.33%

91.09%

-15.72%

RCEL 季節性分析

Historically the probability of a positive October return for RCEL is 26.98%. February offers the highest probability of a positive month at 67.24%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…